Taro Pharmaceutical Industries Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is AZELAIC ACID, MICRONIZED, with a corresponding US DMF Number 29484.
Remarkably, this DMF maintains an Active status since its submission on December 01, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 05, 2016, and payment made on November 30, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II